tiregis comprimate filmate 20 mg
egis pharmaceuticals plc - telmisartanum - comprimate filmate - 20 mg
telmark 40 mg
glenmark pharmaceuticals s.r.o. - republica ceha - telmisartanum - compr. film. - 40mg - antagonisti de angiotensina ii antagonisti de angiotensina ii
telmark 80 mg
glenmark pharmaceuticals s.r.o. - republica ceha - telmisartanum - compr. film. - 80mg - antagonisti de angiotensina ii antagonisti de angiotensina ii
egiramlon 2,5 mg/2,5 mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 2,5mg/2,5mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
egiramlon 5 mg/5 mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 5mg/5mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
egiramlon 5 mg/10mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 5mg/10mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
egiramlon 10 mg/5 mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 10mg/5mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
egiramlon 10 mg/10 mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 10mg/10mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
hartil hct 2,5 mg/12,5mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum+hydrochlorothiazidum) - compr. - 2,5mg/12,5mg - combinatii de inhibitori ai e.c.a. inhibitori ai e.c.a. si diuretice - combinati
thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - agenți antineoplazici - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.